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The activation of a variety of cell surface receptors results in a biphasic increase in the cyto-
plasmic Ca2+ concentration due to the release or mobilization ofCa2" from intracellular stores and
to the entry of Ca2" from the extracellular space. It is well established that phosphatidylinositol
4,5-bisphosphate hydrolysis is responsible for the changes in Ca2+ homeostasis. Stimulation of
Ca2+-mobilizing receptors also results in the phospholipase C-catalyzed hydrolysis of the minor
plasma membrane phospholipid, phosphatidylinositol 4,5-bi8phosphate, with the concomitant for-
mation of inositol (1,4,5) trisphosphate ((1,4,5)IP3) and diacylglycerol. Analogous to the adenylyl
cyclase signaling system, receptor-mediated stimulation of phospholipase C also appears to be
mediated by one or more intermediary guanine nucleotide-dependent regulatory proteins. There
is strong evidence that (1,4,5)IP3 stimulates Ca2+ release from intracellular stores. The Ca2+-
releasing actions of (1,4,5)IP8 are terminated by its metabolism through two distinct pathways.
(1,4,5)IP3 is dephosphorylated by a 5-phosphatase to inositol (1,4) bisphosphate; alternatively,
(1,4,5)IP,, can be phosphorylated to inositol (1,3,4,5) tetrakisphosphate by a 3-kinase. Whereas the
mechanism ofCa2' mobilization is understood, the precise mechanisms involved in Ca2' entry are
not known. A recent proposal that (1,4,5)IP3 secondarily elicits Ca2' entry by emptying an intracel-
lular Ca2+ pool will be considered. This review summarizes our current understanding of the
mechanisms by which inositol phosphates regulate cytoplasmic Ca21 concentrations.
Introduction
An examination of the relationship of phospho-
inositide turnover to Ca2' signaling began in the early
1950s with the observation by Mabel and Lowell
Hokin that the muscarinic cholinergic receptor ago-
nist, acetylcholine, selectively increased the incorpo-
ration of 32Pi into two minor plasma membrane
phospholipids, phosphatidylinositol (PI) and phos-
phatidic acid (1). However, it was not until some 20
years later that Michell, noting that the receptors
that stimulated phosphoinositide turnover also acti-
vated Ca2'-dependent processes in the cell, proposed
that receptor-stimulated phosphoinositide turnover
results in a cellular Ca2' response (2). PI is sequen-
tially phosphorylated by kinases in the cell to
phosphatidylinositol-4-phosphate (PIP) and phospha-
tidylinositol 4,5-bisphosphate (PIP2). Indeed, we now
know that stimulation by any of a number of Ca2'-
mobilizing receptor agonists initially results in the
phospholipase C-catalyzed hydrolysis of PIP2 (3). Fur-
thermore, the Hokins' initial observation of the incor-
poration of 32Pi into PI results from receptor-
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stimulated PIP2 hydrolysis, breakdown of the inositol
phosphates to inositol, and resynthesis of PI.
Phospholipase C-catalyzed PIP2 hydrolysis results
in the formation of the water-soluble inositol (1,4,5)
trisphosphate [(1,4,5)IP3] and the lipid-soluble diacyl-
glycerol. Berridge proposed that (1,4,5)IP3 was the
intracellular messenger that stimulated Ca2" release
from intracellular stores (4). Soon thereafter, the pre-
dicted effect of (1,4,5)IP3 on Ca21 mobilization was
demonstrated; micromolar concentrations of
(1,4,5)IP3 rapidly released Ca2' from a nonmitochon-
drial store in permeabilized pancreatic acinar cells
(5). This result quickly was confirmed in other tissues
in a number of laboratories (6,7). Thus, the evidence is
convincing that (1,4,5)IP3, generated upon activation
ofCa21-mobilizing receptors, releases Ca2" from intra-
cellular stores.
Meanwhile, a parallel story evolved in Nishizuka's
laboratory (8-10), which demonstrated that the other
product of PIP2 hydrolysis, diacylglycerol, also was a
potent intracellular messenger. Diacylglycerol
remains in the plasma membrane to activate a ubiq-
uitous protein kinase, designated as C-kinase by
Nishizuka.
This review briefly summarizes our current under-
standing of the mechanisms by which inositol
phosphates regulate cellular Ca21 metabolism. The
mechanisms involved in receptor activation ofHUGHES AND PUTNEY
phospholipase C, as well as the metabolic pathways
by which the inositol phosphates are interconverted,
are discussed. Finally, proposed mechanisms by
which inositol phosphates elicit intracellular Ca2"




The mechanisms by which cell surface receptors
stimulate phospholipase C have been the focus of con-
siderable research efforts. Much of our current under-
standing of these mechanisms has evolved from the
well-characterized adenylyl cyclase signaling system,
which converts ATP to the intracellular messenger,
3',5'-cyclic AMP. In the adenylyl cyclase system, cell
surface receptors communicate with the adenylyl
cyclase enzyme, located on the cytoplasmic face of the
plasma membrane, through intermediary guanine
nucleotide-dependent regulatory proteins (G-pro-
teins) (11). Two different G-proteins, G. and Gi, link
stimulatory and inhibitory receptors, respectively, to
adenylyl cyclase.
G. and G;, comprised of a, ,3, and y subunits, are two
members of a family of heterotrimeric proteins whose
function is regulated by guanine nucleotides. The a
subunits of this family of G-proteins are heterogene-
ous, whereas the ,3 subunits are quite similar, if not
identical (12).
Activation of G. by hormones (in the presence of
guanine nucleotides) or by guanine nucleotides alone
results in the displacement, by GTP, of the GDP
bound to the a subunit and subsequent dissociation of
the GTP bound-a subunit from the 0/y subunits. This
activated GTP-bound-a subunit stimulates the
adenylyl cyclase enzyme. GTP hydrolysis to GDP by a
GTPase (an inherent activity of the G-proteins) ter-
minates cyclic AMP formation and is assumed to
result in reassociation of the G-protein subunits.
Gi also undergoes subunit dissociation after incuba-
tion with guanine nucleotides. However, the precise
mechanism by which Gi inhibits adenylyl cyclase is
controversial. GTP-bound ai may directly inhibit
adenylyl cyclase (13). Alternatively, inhibition of cyc-
lic AMP formation may occur through the liberation
of a stoichiometric excess of ,/y subunits that associ-
ate with the free a subunits ofG., resulting in enzyme
inhibition (14). Regardless of the precise mechanism
of inhibition of adenylyl cyclase, it appears that G-
protein activation requires dissociation of the protein
into separate a and P/y subunits.
The ability of the adenylyl cyclase-linked G-pro-
teins to be purified, sequenced, and reconstituted into
phospholipid vesicles was due to the capacity of these
proteins to serve as substrates for covalent modifica-
tion by bacterial toxins. That is, G. and Gi are ADP-
ribosylated by cholera and pertussis toxin, respec-
tively. If this toxin-catalyzed ADP-ribosylation is
performed in the presence of 32P-NAD, 32P-ADP-
ribose is covalently transferred to G. and Gi. The
cholera toxin-catalyzed ADP-ribosylation of Gs inhib-
its its inherent GTPase activity to irreversibly acti-
vate Gs. On the other hand, pertussis toxin-catalyzed
ADP-ribosylation of Gi inactivates the protein and
blocks the receptor-mediated inhibition of adenylyl
cyclase.
Receptor-mediated activation of phospholipase C
also appears to involve an intermediary G-protein.
The earliest indication that receptors linked to
phospholipase C might occur through a G-protein(s)
analogous to Gs and Gi was the observation, in a num-
ber of tissues, that guanine nucleotides decreased the
apparent affinity of agonists for receptors known to
stimulate phospholipase C (15-21).
The subsequent observation that guanine nucleo-
tide analogs potentiated the stimulatory actions of
thrombin on diacylglycerol formation, protein phos-
phorylation, and serotonin secretion in permeabilized
platelets provided more direct evidence of the involve-
ment of a G-protein in the receptor activation of
phospholipase C (22,23). Most recently, several labo-
ratories have demonstrated a guanine nucleotide-
mediated activation of phospholipase C in membrane
or permeable cell preparations from a number of cell
types (24-29). The predicted synergistic stimulation
of PIP2 hydrolysis by agonists and guanine nucleo-
tides also has been observed (29,30). Furthermore,
activation of phospholipase C by guanine nucleotides
shows the same relative sensitivity to guanine nucleo-
tide analogs as was observed with the adenylyl
cyclase signaling system (30).
Taken together, the guanine nucleotide dependence
of receptor-stimulated phosphoinositide turnover in
permeabilized cells or in membrane preparations, the
hormonal stimulation of GTPase activity (19), and the
guanine nucleotide regulation of agonist binding to
the Ca21-mobilizing receptors suggest a striking simi-
larity between the G-protein that links cell surface
receptors to phospholipase C and the G-proteins that
couple receptors to the activation and inhibition of
adenylyl cyclase. However, unlike the adenylyl
cyclase system, the precise identity of the G-pro-
tein(s) mediating phospholipase C activation is cur-
rently unknown.
Two general mechanisms have been described for
receptor activation of phosphoinositide turnover.
First, in some systems (including neutrophils and
mast cells), receptor activation of phosphoinositide
turnover is sensitive to inactivation by pertussis toxin
(31-33). This result suggests that Gi or (more likely) a
Gi-like protein regulates phospholipase C in these
cells. However, stimulation of inositol phosphate for-
mation by the majority of phospholipase C-linked
receptors is insensitive to pertussis toxin (30,34,35).
This result is consistent with the hypothesis that a
guanine nucleotide-dependent regulatory protein that
is similar, but not identical to the proteins that regu-
late adenylyl cyclase, links cell surface receptors to
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phospholipase C. This differential sensitivity to per-
tussis toxin may indicate that different G-proteins
regulate phosphoinositide metabolism in different
tissues.
Recently, several toxin-insensitive G-proteins have
been identified and/or purified based on their capac-
ity to bind radiolabeled guanine nucleotides with high
affinity and on the inability of these proteins to serve
as substrates for ADP-ribosylation by pertussis toxin
(36-38). However, to date, the purification and suc-
cessful reconstitution of a pertussis toxin-insensitive
G-protein linked to phospholipase C has not been
achieved.
Inositol Phosphate Metabolism
Inositol phosphates were initially envisioned to be
metabolized through a single, simple pathway that
involved the sequential dephosphorylation of
(1,4,5)IP3 to (1,4)IP2, (1)IP and inositol. However, with
the advent of powerful HPLC analytical procedures
that resolve inositol phosphates with only subtle
structural differences, we now know that inositol
phosphate metabolism is exceedingly complex (Fig.
1). The Ca21-mobilizing actions of (1,4,5)IP3 are termi-
nated by its rapid dephosphorylation to (1,4)IP2 by a
5-phosphatase (39). (1,4)IP2 appears to be
dephosphorylated solely to (4)IP by a relatively non-
specific inositol polyphosphate 1-phosphatase (40).
(4)IP is hydrolyzed by a lithium-sensitive inositol







(193 P2 (3,4)IP2 O1,4)IP2
(1)IP (3)IP M4IP
INOSITOL
FIGURE 1. Metabolic pathways of the inositol phosphates generated
upon phospholipase C-catalyzed hydrolysis of phosphatidyli-
nositol 4,5-bisphosphate (PIP2).
In addition to dephosphorylation of (1,4,5)IP3 by the
5-phosphatase, (1,4,5)IP3 is metabolized through a
second route. In most tissues thus far examined, a 3-
kinase exists that phosphorylates the 3-position of
(1,4,5)IP3 to form (1,3,4,5)IP4 (42). (1,3,4,5)IP4 is
dephosphorylated to a different inositol
trisphosphate, (1,3,4)IP3-presumably by the same 5-
phosphatase that dephosphorylates (1,4,5)IP3.
(1,3,4)IP3 is dephosphorylated primarily to (3,4)IP2 by
the inositol polyphosphate 1-phosphatase (40), and to
a lesser extent, to (1,3)IP2 (43). These inositol
bisphosphates are metabolized to a mixture of (1)IP
and (3)IP, which are stereoisomers, and not resolved
by conventional HPLC methods. The complexity of
the metabolism of (1,4,5)IP3 suggests that inositol
phosphates, in addition to (1,4,5)IP3, may be biologi-
cally active in the cells. Recent evidence, detailed
below, suggests that (1,3,4,5)IP4, together with
(1,4,5)IP3 may modulate Ca2' entry.
An additional complication in inositol phosphate
metabolism is the observation, in vitro, that purified
phospholipase C-catalyzed hydrolysis of PIP2 results
in the formation of (1,4,5)IP3 and cyclic (1:2,4,5)inosi-
tol trisphosphate ((c1:2,4,5)IP3), a derivative with the
1-phosphate cyclized to the 2-hydroxyl (44,45).
(cl:2,4,5)IP3 mobilizes intracellular Ca21 from
permeabilized platelets (46) and 3T3 cells (47) with a
potency similar to that of noncyclic (1,4,5)IP3. How-
ever, (cl:2,4,5)IP3 is not a substrate for the 3-kinase,
and it is degraded by the 5-phosphatase more slowly
than (1,4,5)IP3 (48-50). The slower inactivation of
(cl:2,4,5)IP3 suggests that if it is formed in vivo, it
may cause persistent activation of Ca21 mobilization.
In cholinergically stimulated pancreatic mini-
lobules, Dixon and Hokin determined that the levels
of (1,4,5)IP3 rapidly increased, then fell to a new ele-
vated steady-state, whereas (cl:2,4,5)IP3 slowly accu-
mulated (51). Furthermore, they suggested that
(1,4,5)IP3 could be responsible for intracellular Ca21
release at short times of stimulation, whereas both
(1,4,5)IP3 and (cl:2,4,5)IP3 might contribute equally to
Ca2' release during prolonged stimulation. However,
in most published reports of inositol phosphate for-
mation in vivo, experiments are terminated by the
addition of acid, which cleaves the 1:2 cyclic bond to
yield a mixture of (1,4,5)IP3 and (2,4,5)IP3. To date, an
accurate assessment of the amounts of (cl:2,4,5)IP3
formed in cells, as well as its contribution to the Ca21
response in a variety of tissues, has not been
determined.
Inositol pentakisphosphate (1P5) and inositol hex-
akisphosphate (1P6, phytic acid) also are present in
most mammalian cells. Their levels do not seem to
change upon receptor stimulation (52), suggesting
that they are not formed by phosphorylation of
(1,4,5)IP3 or (1,3,4,5)IP4. Their source and function are
currently unknown, although Vallejo et al. recently
demonstrated that picomolar amounts of IP5 and IP6
elicited marked cardiovascular effects when injected
into specific brain stem regions (53). They suggested
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that IP5 may have extracellular sites of action.
Recently, two novel inositol tetrakisphosphates have
been identified-(1,3,4,6)IP4 which is formed from the
phosphorylation of (1,3,4)IP3 (54,55), and D-
(3,4,5,6)IP4 (56) whose metabolic source is unknown.
These compounds are potential precursor (or metabo-
lite) candidates for IP5 and IP6.
Inositol Phosphates and Ca2+
Release
It is well established that receptor-stimulated Ca2`
mobilization involves an initial release of Ca2' from
intracellular stores, followed by Ca2" entry from the
extracellular space (57,58). This biphasic Ca2`
response can be measured either directly by the fluo-
rescent Ca2` indicators, Quin-2 and Fura-2 (59), or
indirectly by monitoring changes in the Ca2+-depen-
dent processes [such as unidirectional 86Rb+ efflux
through Ca2+-activated K+ channels (60)].
Specifically, the addition of a Ca2'-mobilizing ago-
nist results in a rapid and transient increase in cyto-
plasmic Ca2 , which persists in the absence of
extracellular Ca2+ and, therefore, appears to result
from the release of an intracellular pool of Ca2+. A
sustained phase then follows, which is dependent on
the presence of extracellular Ca2+ and presumably
reflects Ca2+ entry from the extracellular space.
There is strong evidence to support the proposal that
(1,4,5)IP3 mediates intracellular Ca2+ release (61).
The effects of (1,4,5)IP3 were examined in
permeabilized cells and in subcellular fractions under
experimental conditions that would selectively poison
mitochondrial versus nonmitochondrial pools. These
manipulations led a number of laboratories to con-
clude that (1,4,5)IP3 releases Ca2" from an intracellu-
lar pool that was insensitive to inhibitors of
mitochondrial Ca2` uptake and, by default, was likely
to be a component of the endoplasmic reticulum
(5-7,62,63). However, it appears that only a portion of
the Ca21 stored in the endoplasmic reticulum is
released by (1,4,5)IP3. Approximately 30 to 40% of the
exchangeable Ca2+ in the endoplasmic reticulum of
permeabilized hepatocytes is releasable by (1,4,5)IP3
(6,64), which suggests that the remaining Ca2' is pre-
sent in a pool not regulated by (1,4,5)IP3.
Ca2+ Entry
Whereas the evidence is quite convincing that
(1,4,5)IP3 is the intracellular signal that mobilized
intracellular Ca2+, the second phase of the Ca2"
response-namely, Ca2+ entry-is not well under-
stood. The inositol phosphates, particularly (1,4,5)IP3,
also may be important in Ca2` entry. Microinjection
of inositol phosphates into sea urchin eggs or lacrimal
cells results in cell responses requiring both Ca2`
release and Ca2" entry (65-67). In addition, the appli-
cation of (1,4,5)IP3 to excised patches of T lympho-
cytes elicits Ca2" channel activity similar to that
observed by the addition of agonist, suggesting that
(1,4,5)IP3 activates Ca2" channels in the plasma mem-
brane (68).
However, in other systems, (1,4,5)IP3 does not
directly increase the permeability of plasma mem-
brane vesicles to Ca2' (69,70). This suggests that if
(1,4,5)IP3 promotes Ca2+ entry into cells, the site of
action of (1,4,5)IP3 is not at the plasma membrane.
Recently, a capacitative mechanism was proposed
in which (1,4,5)IP3 secondarily promotes Ca2+ entry
(71), by emptying intracellular Ca21 stores. We know
that the ability of a cell to respond to a second Ca2+_
mobilizing agonist, following the termination of the
first stimulus, depends on the refilling of the IP3-
sensitive intracellular pool (60,72). Under resting con-
ditions, this IP3-sensitive intracellular Ca2' store is
resistant to depletion by extracellular chelating
agents. However, upon depletion, refilling of this pool
only occurs in the presence of extracellular Ca2+. This
refilling process occurs after the termination of the
first stimulus (and presumably in the absence of
intracellular messengers, such as inositol
phosphates). This intracellular pool appears to be in
close apposition to the plasma membrane because the
refilling process occurs with only a small increase in
the cytoplasmic Ca2+ concentration (59). According to
this capacitative model, emptying of the intracellular
Ca2+ pool by IP3 permits the direct communication of
this pool with the plasma membrane. In the presence
of extracellular Ca2+, Ca2+ enters the cell through this
interface and subsequently into they cytosol. When
IP3 is degraded, extracellular Ca2+ continues to enter
the cell via this interface until the intracellular Ca2+
pool is restored.
As previously mentioned, (1,3,4,5)IP4 possesses no
Ca2+-releasing activity (47); thus, the metabolism of
(1,4,5)IP3 to (1,3,4,5)IP4 simply may terminate the
actions of (1,4,5)IP3. However, recent evidence sug-
gests that (1,3,4,5)IP4 may be important in the second
phase of the cellular Ca2+ response, namely Ca2+
entry. In sea urchin eggs, the injection of (1,4,5)IP3
results in cell activation (the raising of a fertilization
envelope), a response believed to require both Ca2+
release as well as Ca2+ entry (65,66).
Irvine and Moor demonstrated that the injection of
(2,4,5)IP3, which releases intracellular Ca2+ but which
presumably is not phosphorylated to IP4 (50), resulted
in the activation of many fewer cells (66). Similarly,
microinjection of (1,3,4,5)IP4 alone failed to raise a
fertilization envelope. However, when (2,4,5)IP3,
which releases Ca2+, was injected together with
(1,3,4,5)IP4, a full cellular response was observed.
They suggested that when (1,4,5)IP3 is injected, it
causes Ca2+ release, but that activation of Ca2+ entry
requires its phosphorylation to (1,3,4,5)IP4. However,
since (1,3,4,5)IP4 only was active when injected with
the Ca2+-releasing (2,4,5)IP3, they concluded that the
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emptying of the intracellular Ca2" pool appeared to be
a prerequisite to Ca2l entry. Furthermore, the role of
(1,4,5)IP3 could not be mimicked by artificially raising
the cytoplasmic Ca2" concentration (73). Thus, it
appears that in intact cells, both (1,4,5)IP3 and
(1,3,4,5)IP4 levels must increase for the full Ca2"
response.
In more recent experiments, Morris et al. (67)
demonstrated that in perfused lacrimal acinar cells,
(1,3,4,5)IP4 was required in the perfusate to observe
effects of (1,4,5)IP3 on either the initial transient or
later sustained phase ofCa2" mobilization. This might
indicate that (1,3,4,5)IP4 is required for (1,4,5)IP3-
induced Ca2" release as well as entry. Somewhat para-
doxically, (1,4,5)IP3 alone is fully capable of emptying
intracellular Ca2" stores when applied to microsomal
preparations or permeable cells (which would corre-
spond to the initial transient phase of the Ca2"
response in the lacrimal cells). Thus, despite the
striking effects of (1,3,4,5)IP4 demonstrated in the sea
urchin egg and lacrimal cell experiments, the precise
mechanism by which (1,3,4,5)IP4 acts in the Ca2+-sig-
naling pathway remains to be resolved.
Conclusions
Virtually our entire understanding of the mecha-
nisms by which the inositol phosphates regulate the
Ca2"-signaling system has evolved within the last 5
years. Whereas (1,4,5)IP3 has been accepted as the
signal that elicits intracellular Ca2' release, the sec-
ond phase of the cellular Ca2' response, namely Ca2'
entry, is less understood. Furthermore, the complex-
ity of the metabolism of the inositol phosphates (with
its alternative phosphorylation/dephosphorylation
pathways) implies that additional inositol phosphates
may be biologically active. It seems safe to predict
that as our knowledge of the phosphoinositide/Ca2+-
signaling system increases, our unanswered questions
will increase as well.
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